Martin Hunt
Vermögen: 78 100 $ am 30.06.2026
Vermögen: 78 100 $ am 30.06.2026
Martin Braddock Hunt currently works at Videregen Ltd., as Chairman, i4i LP, as Programme Director, Invictus Management Ltd., as Director, and National Institute For Health & Care Research, as Programme Director.
Mr. Hunt also formerly worked at Tissue Science Laboratories Ltd., as Chief Executive Officer, MDY Healthcare Ltd., as Deputy Chairman, Trophos SA, as Vice Chairman-Supervisory Board, SkinBioTherapeutics Plc, as Non-Executive Chairman from 2016 to 2026, Wyeth Holdings LLC, as Marketing Director-Europe, Middle East & Africa, ArcticZymes Technologies ASA, as Director, DYSIS Medical Ltd., as Director in 2012, Tissue Science Laboratories (UK) Ltd., as Director, Regentix Ltd., as Director, Orthox Ltd., as Non-Executive Director, and Bristol Myers Squibb Co., as Vice President-Europe Sales from 1994 to 1996.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 560’417 ( 0.22% ) | 78 100 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Invictus Management Ltd.
Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Direktor/Vorstandsmitglied | 13.12.2010 |
National Institute For Health & Care Research
National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services Engages in improving the health and wealth of the nation through research | Corporate Officer/Principal | - |
i4i LP | Corporate Officer/Principal | - |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
Tissue Science Laboratories (UK) Ltd. | Direktor/Vorstandsmitglied | - |
| ARCTICZYMES TECHNOLOGIES ASA | Direktor/Vorstandsmitglied | - |
| SKINBIOTHERAPEUTICS PLC | Vorsitzender | - |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention of neuronal loss for neurodegenerative diseases | Direktor/Vorstandsmitglied | - |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Vorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
i4i LP | |
MDY Healthcare Ltd.
MDY Healthcare Ltd. Financial ConglomeratesFinance Invests in healthcare sector companies | Finance |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Health Technology |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention of neuronal loss for neurodegenerative diseases | Health Technology |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Health Technology |
Tissue Science Laboratories (UK) Ltd. | |
Regentix Ltd. | |
Invictus Management Ltd.
Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
Orthox Ltd.
Orthox Ltd. BiotechnologyHealth Technology Develops tissue regenerative implants | Health Technology |
National Institute For Health & Care Research
National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services Engages in improving the health and wealth of the nation through research | Commercial Services |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Operates a regenerative medicine company created to address the chronic shortage of organs for transplantation | Health Technology |
SkinBioTherapeutics Plc
SkinBioTherapeutics Plc Pharmaceuticals: OtherHealth Technology Develops and sells probiotic food supplements and skincare ingredients for the cosmetics industry | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen